Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2011 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients.
JAMA. 2010 Jul 21;304(3):275-83. doi: 10.1001/jama.2010.926.
JAMA. 2010.
PMID: 20639561
Free PMC article.
Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.
Goepfert PA, Elizaga ML, Sato A, Qin L, Cardinali M, Hay CM, Hural J, DeRosa SC, DeFawe OD, Tomaras GD, Montefiori DC, Xu Y, Lai L, Kalams SA, Baden LR, Frey SE, Blattner WA, Wyatt LS, Moss B, Robinson HL; National Institute of Allergy and Infectious Diseases HIV Vaccine Trials Network.
Goepfert PA, et al.
J Infect Dis. 2011 Mar 1;203(5):610-9. doi: 10.1093/infdis/jiq105. Epub 2011 Jan 31.
J Infect Dis. 2011.
PMID: 21282192
Free PMC article.
Clinical Trial.
Item in Clipboard
An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study).
Fitzgerald DW, Janes H, Robertson M, Coombs R, Frank I, Gilbert P, Loufty M, Mehrotra D, Duerr A; Step Study Protocol Team.
Fitzgerald DW, et al.
J Infect Dis. 2011 Mar 15;203(6):765-72. doi: 10.1093/infdis/jiq114.
J Infect Dis. 2011.
PMID: 21343146
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite